254 related articles for article (PubMed ID: 28239651)
1. Profiling of circulating microRNAs in children with recent onset of type 1 diabetes.
Erener S; Marwaha A; Tan R; Panagiotopoulos C; Kieffer TJ
JCI Insight; 2017 Feb; 2(4):e89656. PubMed ID: 28239651
[TBL] [Abstract][Full Text] [Related]
2. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
Front Immunol; 2019; 10():1637. PubMed ID: 31396209
[TBL] [Abstract][Full Text] [Related]
3. miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3.
Zurawek M; Dzikiewicz-Krawczyk A; Izykowska K; Ziolkowska-Suchanek I; Skowronska B; Czainska M; Podralska M; Fichna P; Przybylski G; Fichna M; Nowak J
Diabetes Res Clin Pract; 2018 Aug; 142():146-153. PubMed ID: 29859273
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.
Nielsen LB; Wang C; Sørensen K; Bang-Berthelsen CH; Hansen L; Andersen ML; Hougaard P; Juul A; Zhang CY; Pociot F; Mortensen HB
Exp Diabetes Res; 2012; 2012():896362. PubMed ID: 22829805
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes.
Satake E; Pezzolesi MG; Md Dom ZI; Smiles AM; Niewczas MA; Krolewski AS
Diabetes; 2018 May; 67(5):1013-1023. PubMed ID: 29453204
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls.
Swolin-Eide D; Forsander G; Pundziute Lyckå A; Novak D; Grillari J; Diendorfer AB; Hackl M; Magnusson P
Sci Rep; 2023 Jul; 13(1):11634. PubMed ID: 37468555
[TBL] [Abstract][Full Text] [Related]
8. Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity.
Garavelli S; Bruzzaniti S; Tagliabue E; Prattichizzo F; Di Silvestre D; Perna F; La Sala L; Ceriello A; Mozzillo E; Fattorusso V; Mauri P; Puca AA; Franzese A; Matarese G; Galgani M; de Candia P
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940853
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
11. miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes.
Marchand L; Jalabert A; Meugnier E; Van den Hende K; Fabien N; Nicolino M; Madec AM; Thivolet C; Rome S
J Diabetes Res; 2016; 2016():1869082. PubMed ID: 27314045
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Differentially Expressed MicroRNAs in OVA-induced Airway Remodeling Model Mice.
Xu C; Song Y; Wang C; Jiang J; Wang Z; Li L; Yan G
Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):524-536. PubMed ID: 36341561
[TBL] [Abstract][Full Text] [Related]
13. Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling.
Mäkitie RE; Hackl M; Niinimäki R; Kakko S; Grillari J; Mäkitie O
J Clin Endocrinol Metab; 2018 May; 103(5):1985-1996. PubMed ID: 29506076
[TBL] [Abstract][Full Text] [Related]
14. The analysis of Modified Qing' E Formula on the differential expression of exosomal miRNAs in the femoral head bone tissue of mice with steroid-induced ischemic necrosis of femoral head.
Zhu W; Zhang F; Lu J; Ma C; Shen L; Hu D; Xu X; Shuai B
Front Endocrinol (Lausanne); 2022; 13():954778. PubMed ID: 36034465
[TBL] [Abstract][Full Text] [Related]
15. MiR-885-3p is down-regulated in peripheral blood mononuclear cells from T1D patients and regulates the inflammatory response via targeting TLR4/NF-κB signaling.
Zhang X; Gu H; Wang L; Huang F; Cai J
J Gene Med; 2020 Jan; 22(1):e3145. PubMed ID: 31763742
[TBL] [Abstract][Full Text] [Related]
16. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
Collares CV; Evangelista AF; Xavier DJ; Rassi DM; Arns T; Foss-Freitas MC; Foss MC; Puthier D; Sakamoto-Hojo ET; Passos GA; Donadi EA
BMC Res Notes; 2013 Nov; 6():491. PubMed ID: 24279768
[TBL] [Abstract][Full Text] [Related]
17. Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period.
Frørup C; Mirza AH; Yarani R; Nielsen LB; Mathiesen ER; Damm P; Svare J; Engelbrekt C; Størling J; Johannesen J; Mortensen HB; Pociot F; Kaur S
Front Immunol; 2021; 12():744509. PubMed ID: 34691048
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
19. Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease.
Santos AS; Ferreira LRP; da Silva AC; Alves LI; Damasceno JG; Kulikowski L; Cunha-Neto E; da Silva MER
J Immunol Res; 2022; 2022():2734490. PubMed ID: 35903753
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses.
Assmann TS; Recamonde-Mendoza M; Costa AR; Puñales M; Tschiedel B; Canani LH; Bauer AC; Crispim D
Acta Diabetol; 2019 Jan; 56(1):55-65. PubMed ID: 30167868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
